Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

365
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
365
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

394
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
394
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

199
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
199
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.5K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.5K
Defense Mechanism Against Infection01:26

Defense Mechanism Against Infection

8.6K
Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Closing the Gap to Interventions for Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND): Protocol for a Longitudinal Study of TAND Severity, Predictors, and Caregiver Well-Being (TANDem-2).

JMIR research protocols·2026
Same author

Early access disparities in innovative therapies across the US, EU, China, and Japan.

Frontiers in medicine·2025
Same author

COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion review.

The oncologist·2025
Same author

Generational differences in healthcare: the role of technology in the path forward.

Frontiers in public health·2025
Same author

Adoption of Digital Therapeutics in Europe.

Therapeutics and clinical risk management·2025
Same author

Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals.

Advances in therapy·2024

Related Experiment Video

Updated: Dec 6, 2025

Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs
07:13

Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs

Published on: April 9, 2021

4.5K

Reflections on the Collaborative Fight Against COVID-19.

Michel Goldman1, Mitchell Silva2

  • 1Institute for Interdisciplinary Innovation in Healthcare (I3h), Université Libre de Bruxelles, Brussels, Belgium.

Frontiers in Medicine
|October 12, 2020
PubMed
Summary

Patient involvement is crucial for designing effective COVID-19 treatments. Including patient organizations ensures clinical trials focus on relevant outcomes and accurately assess new therapy risks and benefits.

Keywords:
COVID-19partnershippatientregulationtrial

More Related Videos

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.1K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.6K

Related Experiment Videos

Last Updated: Dec 6, 2025

Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs
07:13

Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs

Published on: April 9, 2021

4.5K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.1K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.6K

Area of Science:

  • Infectious Diseases
  • Clinical Trial Design
  • Patient-Centered Research

Background:

  • Numerous clinical trials are underway globally to find effective COVID-19 treatments.
  • Historically, patient perspectives have been underrepresented in the design of these trials.
  • Emerging interest in early-phase COVID-19 therapeutic interventions necessitates a shift in trial methodology.

Purpose of the Study:

  • To advocate for the inclusion of patient organizations in the design of clinical protocols for COVID-19 treatments.
  • To emphasize the importance of patient input in defining relevant clinical trial endpoints.
  • To highlight the need for patient involvement in assessing the risk-benefit balance of novel therapies.

Main Methods:

  • This study presents a perspective and argument for patient involvement.
  • It reviews the current landscape of COVID-19 clinical trials.
  • It proposes a framework for integrating patient organizations into trial design.

Main Results:

  • Current clinical trial designs for COVID-19 treatments often overlook patient priorities.
  • Integrating patient organizations can lead to more meaningful and relevant trial outcomes.
  • Patient input is essential for a comprehensive risk-benefit assessment.

Conclusions:

  • Patient organizations should be integral to the design of COVID-19 clinical trials.
  • Involving patients ensures that trial endpoints and risk-benefit assessments align with patient values.
  • This collaborative approach will enhance the relevance and efficiency of therapeutic development for COVID-19.